Norway Savings Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-60
Closed -$16.6K 154
2022
Q4
$16.6K Hold
60
0.01% 230
2022
Q3
$16K Buy
60
+40
+200% +$8.49K 0.01% 230
2022
Q2
$4K Hold
20
﹤0.01% 265
2022
Q1
$4K Hold
20
﹤0.01% 271
2021
Q4
$5K Hold
20
﹤0.01% 277
2021
Q3
$6K Hold
20
﹤0.01% 280
2021
Q2
$7K Hold
20
﹤0.01% 282
2021
Q1
$6K Hold
20
﹤0.01% 281
2020
Q4
$5K Hold
20
﹤0.01% 299
2020
Q3
$6K Hold
20
﹤0.01% 267
2020
Q2
$5K Buy
+20
New +$6.01K ﹤0.01% 234
2019
Q1
Sell
-844
Closed -$254K 243
2018
Q4
$254K Sell
844
-12
-1% -$3.83K 0.25% 81
2018
Q3
$302K Sell
856
-215
-20% -$74K 0.26% 79
2018
Q2
$311K Sell
1,071
-33
-3% -$9.28K 0.28% 76
2018
Q1
$302K Sell
1,104
-37
-3% -$11.5K 0.29% 75
2017
Q4
$363K Sell
1,141
-10
-0.9% -$3.21K 0.34% 69
2017
Q3
$360K Sell
1,151
-30
-3% -$8.88K 0.35% 70
2017
Q2
$320K Sell
1,181
-10
-0.8% -$2.64K 0.31% 73
2017
Q1
$325K Sell
1,191
-515
-30% -$146K 0.33% 72
2016
Q4
$484K Buy
+1,706
New +$506K 0.45% 64

Other funds holding BIIB

Norway Savings Bank's BIIB Position: Q1 2023 in Review

Norway Savings Bank sold out of Biogen (BIIB) in Q1 2023, closing a stake of 60 shares — an estimated $16.6K sold.

Norway Savings Bank first reported a position in BIIB in Q4 2016 and held it in 20 quarters. The position peaked at $484K in Q4 2016. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Norway Savings Bank reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Norway Savings Bank sold 60 Biogen shares in Q1 2023, an estimated $16.6K.
  • Norway Savings Bank first reported a position in Biogen in Q4 2016 and held it in 20 quarters.
  • Norway Savings Bank's Biogen position peaked at $484K in Q4 2016.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Norway Savings Bank's 13F filing for Q1 2023, filed 11 Apr 2023.